Filtros de búsqueda

Lista de obras de

ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase

artículo científico publicado en 2013

Advances in the medical treatment of Cushing's syndrome

scientific article published on 20 July 2018

Comorbidities in Cushing's disease

artículo científico publicado en 2015

Cushing's syndrome

artículo científico publicado en 2015

Cushing's syndrome: epidemiology and developments in disease management

artículo científico publicado en 2015

Diagnostic imaging of dopamine receptors in pituitary adenomas

artículo científico publicado en 2007

Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN.

artículo científico publicado en 2017

Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors

artículo científico publicado en 2019

Effects of therapy with [177Lu-DOTA 0,Tyr 3]octreotate on endocrine function

artículo científico publicado en 2009

Endoscopic bilateral adrenalectomy in patients with ectopic Cushing’s syndrome

artículo científico publicado el 2 de noviembre de 2011

Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate.

artículo científico publicado en 2008

Inhibin alpha-subunit (INHA) expression in adrenocortical cancer is linked to genetic and epigenetic INHA promoter variation

artículo científico publicado en 2014

Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors.

artículo científico publicado en 2017

Melanocortin 2 Receptor-Associated Protein (MRAP) and MRAP2 in Human Adrenocortical Tissues: Regulation of Expression and Association with ACTH Responsiveness

artículo científico publicado el 14 de marzo de 2012

Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion

artículo científico publicado en 2011

Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [177Lu-DOTA0,Tyr3]Octreotate

scientific article published on 13 August 2015

Pitfalls in the response evaluation after peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate

artículo científico publicado en 2017

Preoperative medical treatment in Cushing's syndrome. Frequency of use and its impact on postoperative assessment. Data from ERCUSYN.

artículo científico publicado en 2018

Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors

artículo científico publicado en 2005

Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome

artículo científico publicado en 2012

Safety and efficacy of everolimus in gastrointestinal and pancreatic neuroendocrine tumors after (177)Lu-octreotate.

artículo científico publicado en 2013

Salvage therapy with (177)Lu-octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumors

artículo científico publicado en 2010

Somatostatin receptor imaging for neuroendocrine tumors

artículo científico publicado en 2006

Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives.

artículo científico publicado en 2019

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

artículo científico publicado en 2008